Investing.com - AstraZeneca (NASDAQ:AZN) ADR reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AstraZeneca ADR announced earnings per share of $1.63 on revenue of $7.32B. Analysts polled by Investing.com anticipated EPS of $0.6832 on revenue of $7.03B.
AstraZeneca ADR shares are up 2.76% from the beginning of the year and are trading at $51.37 , down-from-52-week-high.They are under-performing the Nasdaq which is up 9.27% from the start of the year.
AstraZeneca ADR follows other major Healthcare sector earnings this month
AstraZeneca ADR's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar